These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11475811)

  • 1. [Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].
    Benedetti-Bardet C; Guy C; Boudignat O; Regnier-Zerbib A; Ollagnier M;
    Therapie; 2001; 56(3):295-9. PubMed ID: 11475811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].
    Castot A; Bidault I; Dahan R; Efthymiou ML
    Therapie; 1993; 48(5):469-74. PubMed ID: 8146827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
    Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
    Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights of the 22nd French pharmacovigilance meeting.
    Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
    Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
    Mazé F; Bégaud B
    Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].
    Aguirre C; Haramburu F
    Therapie; 1995; 50(6):563-9. PubMed ID: 8745957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug vigilance: opinion survey among residents of a university hospital].
    Graille V; Lapeyre-Mestre M; Montastruc JL
    Therapie; 1994; 49(5):451-4. PubMed ID: 7855763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
    Rabaud C; May T; Beuscart C; Reynes J; Leport C; Canton P
    Ann Med Interne (Paris); 1998 Mar; 149(2):62-6. PubMed ID: 11490526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].
    Imbs JL; Pouyanne P; Haramburu F; Welsch M; Decker N; Blayac JP; Bégaud B
    Therapie; 1999; 54(1):21-7. PubMed ID: 10216418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.
    Morel P; Vandel B
    Therapie; 1999; 54(5):525-32. PubMed ID: 10667084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects of quinine in the treatment of leg cramps].
    Beyens MN; Guy C; Ollagnier M
    Therapie; 1999; 54(1):59-62. PubMed ID: 10216424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhizin: an alternate drug for Pneumocystis carinii pneumonia in AIDS patients.
    Badam L
    J Assoc Physicians India; 2002 Feb; 50():287-8. PubMed ID: 12038674
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.